Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.

[1]  Patrick W Serruys,et al.  Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? , 2012, European heart journal.

[2]  Michael C. McDaniel,et al.  Coronary Artery Wall Shear Stress Is Associated With Progression and Transformation of Atherosclerotic Plaque and Arterial Remodeling in Patients With Coronary Artery Disease , 2011, Circulation.

[3]  R. Virmani,et al.  Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies , 2011, The International Journal of Cardiovascular Imaging.

[4]  Patrick W. Serruys,et al.  Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond , 2011, The International Journal of Cardiovascular Imaging.

[5]  Bernard Chevalier,et al.  A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. , 2010, JACC. Cardiovascular interventions.

[6]  Patrick W Serruys,et al.  Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. , 2010, JACC. Cardiovascular interventions.

[7]  A. Maseri,et al.  Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. , 2009, The American journal of cardiology.

[8]  Young-Hak Kim,et al.  Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. , 2009, JACC. Cardiovascular interventions.

[9]  D. Holmes,et al.  Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques , 2009, Heart.

[10]  A. Kastrati,et al.  Distribution of angiographic measures of restenosis after drug-eluting stent implantation , 2009, Heart.

[11]  Kyung-Sook Park,et al.  The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. , 2008, The American journal of cardiology.

[12]  Patrick W. Serruys,et al.  Caracterización de los efectos tisulares en los segmentos adyacentes a los stents liberadores de paclitaxel según el análisis de datos de radiofrecuencia procedentes de ecocardiografía intravascular seriada: estudio BETAX (BEside TAXus) , 2008 .

[13]  P. Serruys,et al.  Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. , 2008, Revista espanola de cardiologia.

[14]  Theodore A Bass,et al.  Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). , 2008, The American journal of cardiology.

[15]  G. D. De Meyer,et al.  Selective clearance of macrophages in atherosclerotic plaques by autophagy. , 2007, Journal of the American College of Cardiology.

[16]  P. Fitzgerald,et al.  Vascular response to sirolimus‐eluting stents delivered with a nonaggressive implantation technique: Comparison of intravascular ultrasound results from the multicenter, randomized E‐SIRIUS, and SIRIUS trials , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  R. Virmani,et al.  Extracellular Matrix Changes in Stented Human Coronary Arteries , 2004, Circulation.

[18]  R. Whitbourn,et al.  Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis From the TAXUS II Trial , 2004, Circulation.

[19]  Renu Virmani,et al.  Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans , 2003, Circulation.

[20]  Nikos Stergiopulos,et al.  Shear stress, vascular remodeling and neointimal formation. , 2003, Journal of biomechanics.

[21]  Mary E. Russell,et al.  TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.

[22]  Attila Thury,et al.  Images in cardiovascular medicine. Focal in-stent restenosis near step-up: roles of low and oscillating shear stress? , 2002, Circulation.

[23]  J J Wentzel,et al.  Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution. , 2000, Journal of biomechanics.

[24]  V. Bhargava,et al.  Axial movement of the intravascular ultrasound probe during the cardiac cycle: implications for three-dimensional reconstruction and measurements of coronary dimensions. , 1999, American heart journal.

[25]  C von Birgelen,et al.  ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. , 1998, Catheterization and cardiovascular diagnosis.

[26]  C J Slager,et al.  ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. , 1997, Circulation.

[27]  Gianni Pedrizzetti,et al.  Flow-tissue interaction with compliance mismatch in a model stented artery. , 2004, Journal of biomechanics.

[28]  R. Geuns,et al.  Images in Cardiovascular Medicine , 2000 .